In December 2020, Natco Pharma had announced the launch of an anticoagulant medication named Rivaroxaban (RPIGAT). Rivaroxaban is an anticoagulant drug that treats and prevents blood clots. In India, Bayer markets the drug as Xarelto.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
